von Tobias Borgers | Dez 21, 2023 | Boehringer
This webcast features: Athelney Woolnough, Director Business Development/Key Account Management BioXcellence, Franz Schuster, Strategy Implementation Manager Biopharma Austria, Cécile Brocard, Director of Downstream Development, Process Science RCV, Boehringer...
von Tobias Borgers | Dez 21, 2023 | Boehringer
RealmFive, a leader in data connectivity and digital solutions based in Lincoln, Neb., has teamed up with Boehringer Ingelheim Animal Health, to commercialize next-generation technology-based solutions for advancing remote connectivity and herd health across the swine...
von Tobias Borgers | Dez 14, 2023 | Markt
The biopharmaceutical sector is the fastest-growing part of the pharma industry, representing global revenues of $163 billion—about 20 percent of the total pharma market—and growing fast. Biopharma’s current annual growth rate of more than eight percent is double that...
von Tobias Borgers | Nov 23, 2023 | Markt
ESG (environment, social and corporate governance) climate change and health equity: Unequivocal evidence links physical and mental health with climate change, highlighting the crucial role of all stakeholders in the health ecosystem.27 Evolving regulatory standards...
von Tobias Borgers | Nov 8, 2023 | IMA
On July 18th 2023, IMA completed the closing for the purchase of 70% of Mespic S.r.l., a company based in Faenza (Ravenna), and 100% of its Illinois-based subsidiary Mespic North America Corporation, from its sole shareholder Holding FGLG S.r.l.. Mespic, founded in...
